Idiopathic scrotal calcinosis is idiopathic.

Idiopathic scrotal calcinosis: a non-elucidated pathogenesis and its surgical treatment. Rev Urol (2011) 1.31

Idiopathic calcinosis cutis of the penis. J Clin Aesthet Dermatol (2012) 0.93

Idiopathic calcinosis cutis of the penis. Indian Dermatol Online J (2010) 0.77

Scrotal calcinosis. J Am Acad Dermatol (1992) 0.75

Scrotal calcinosis: pathogenetic link with epidermal cyst. BMJ Case Rep (2015) 0.75

Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature (1997) 6.89

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (1998) 6.16

Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet (2000) 3.39

A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature (1992) 2.49

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst (1996) 2.28

Keratin antigens in differentiating skin. Ann N Y Acad Sci (1985) 2.10

High levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion. Br J Dermatol (2014) 2.09

Antibody markers of basal cells in complex epithelia. J Cell Sci (1990) 2.08

Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci (1989) 2.07

Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol (2000) 2.03

Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol (1996) 2.00

Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol (1995) 1.96

Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol (1991) 1.88

Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol (1991) 1.87

Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78

Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev (1996) 1.75

Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. J Invest Dermatol (1995) 1.69

Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet (1997) 1.68

Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J Cell Biol (1999) 1.64

Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet (2006) 1.64

Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol (1989) 1.61

Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br J Dermatol (1985) 1.58

Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis. J Clin Invest (1992) 1.58

Intraepidermal type VII collagen. Evidence for abnormal intracytoplasmic processing of a major basement membrane protein in rare patients with dominant and possibly localized recessive forms of dystrophic epidermolysis bullosa. J Am Acad Dermatol (1990) 1.54

Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression. Am J Pathol (1990) 1.53

Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet (1999) 1.52

Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51

Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur J Hum Genet (2000) 1.48

A functional "knockout" of human keratin 14. Genes Dev (1994) 1.48

Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol (1989) 1.46

Immunohistochemical analysis of burn depth. J Burn Care Rehabil (1999) 1.46

Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol (1999) 1.46

Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet (2001) 1.42

Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet (1992) 1.41

Immortalisation of human urothelial cells. Urol Res (1995) 1.38

A novel human type II cytokeratin, K6hf, specifically expressed in the companion layer of the hair follicle. J Invest Dermatol (1998) 1.37

Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol (2005) 1.37

N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet (1999) 1.35

Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol (1987) 1.33

Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol (1997) 1.32

Treatment of erythema multiforme secondary to herpes simplex by prophylactic topical acyclovir. Br Med J (Clin Res Ed) (1981) 1.30

Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and in ras-transfected tumorigenic clones. Differentiation (1989) 1.30

Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat Genet (1997) 1.25

The role of fibroblasts in tissue engineering and regeneration. Br J Dermatol (2007) 1.23

Localisation of a gene for Papillon-Lefèvre syndrome to chromosome 11q14-q21 by homozygosity mapping. Hum Genet (1997) 1.21

Prophylactic topical acyclovir for frequent recurrent herpes simplex infection with and without erythema multiforme. Br Med J (Clin Res Ed) (1983) 1.21

Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol (2004) 1.20

Generation and characterization of epidermolysis bullosa simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br J Dermatol (2003) 1.19

Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol (1991) 1.19

Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol (1999) 1.16

Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res (1993) 1.16

Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Hum Genet (2000) 1.15

Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis. Br J Dermatol (1986) 1.15

Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol (1999) 1.14

Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J Cell Sci (1995) 1.14

Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol (1991) 1.12

Specialized keratin expression pattern in human ridged skin as an adaptation to high physical stress. Br J Dermatol (1998) 1.10

Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients. Lancet (1997) 1.10

Non-melanoma skin cancer in renal transplant recipients: the extent of the problem and a strategy for management. Br J Plast Surg (1994) 1.10

Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol (1993) 1.09

Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp Dermatol (2000) 1.08

Human in vivo cellular response to a cross-linked acellular collagen implant. Br J Surg (2008) 1.08

Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis. J Invest Dermatol (2000) 1.06

Keratin expression in basal cell carcinomas. Br J Dermatol (1992) 1.06

Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol (1998) 1.06

Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. J Invest Dermatol (2001) 1.05

Keratin 17 expression as a marker for epithelial transformation in viral warts. Am J Pathol (1993) 1.05

Woolly hair naevi with systematized linear epidermal naevus. Clin Exp Dermatol (1986) 1.03

Spectrum of dominant mutations in the desmosomal cadherin desmoglein 1, causing the skin disease striate palmoplantar keratoderma. Eur J Hum Genet (2001) 1.03

Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol (1993) 1.03

A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant (2012) 1.02

Skin graft storage and keratinocyte viability. Br J Plast Surg (1993) 1.02

Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells. Clin Cancer Res (1999) 1.00

Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol (1994) 1.00

Keratinocyte differentiation in psoriatic scalp: morphology and expression of epithelial keratins. Br J Dermatol (1994) 0.99

Culture and characterisation of human urothelium in vivo and in vitro. Urol Res (1994) 0.99

Altered keratinocyte growth and differentiation in psoriasis. Clin Dermatol (1995) 0.99

Recurrent and continuous erythema multiforme--a clinical and immunological study. Clin Exp Dermatol (1985) 0.98

Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations. Eur J Cancer B Oral Oncol (1994) 0.98

Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma. Oncogene (2011) 0.98

Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol (1992) 0.98

Formation of hemidesmosome-like structures in the absence of ligand binding by the (alpha)6(beta)4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the (beta)4 integrin subunit. J Cell Sci (2000) 0.98

The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J (1999) 0.97

Culturing skin in vitro for wound therapy. Trends Biotechnol (1995) 0.96

Keratin expression in the normal nail unit: markers of regional differentiation. Br J Dermatol (2000) 0.95

Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita. J Invest Dermatol (2001) 0.95

Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18. Histopathology (1992) 0.95

Epidermolytic acanthomas: clinical characteristics and immunohistochemical features. Am J Dermatopathol (1997) 0.95

Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol (1994) 0.95

Cloning and characterization of ERF-1, a human member of the Tis11 family of early-response genes. DNA Cell Biol (1994) 0.95

Ichthyosis bullosa of Siemens--a disease involving keratin 2e. J Invest Dermatol (1994) 0.95

E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J Virol (1996) 0.95

Linkage of autosomal dominant dystrophic epidermolysis bullosa in three British families to the marker D3S2 close to the COL7A1 locus. J Med Genet (1992) 0.95

Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeleton function. Nat Genet (1993) 0.94

Expression of intermediate filament proteins in fetal and adult human lung tissues. Differentiation (1989) 0.94

A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. Lepr Rev (1987) 0.94

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours. Br J Cancer (2006) 0.94